Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
206 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Recruiting - Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Recruiting - the Alfred Hospital
Melbourne, Victoria, Australia
Recruiting - Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Recruiting
- Allgemeinen Krankenhaus (akh) Wien - Medizinische Universitaet Wien
Vienna, Austria
Recruiting
- Jules Bordet Institut
Anderlecht, Belgium
Recruiting - Universitair Ziekenhuis Brussel
Brussels, Belgium
Recruiting - Local Institution - 05200
Ghent, Belgium
Withdrawn - Uz Gent
Ghent, Belgium
Recruiting - Local Institution - Unk 2
Leuven, Belgium
Withdrawn - University Hospital Leuven
Leuven, Belgium
Recruiting
- University of Calgary
Calgary, Alberta, Canada
Recruiting - Local Institution - 02802
Vancouver, British Columbia, Canada
Withdrawn - Local Institution - 02801
Hamilton, Ontario, Canada
Withdrawn - Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Recruiting - Ciusss de L'Est-de-L'Ile-de-Montreal
Montreal, Quebec, Canada
Recruiting
- Helsinki University Central Hospital (huch)
Helsinki, Finland
Recruiting
- Hopital Henri Mondor
Creteil-Paris, France
Recruiting - Chru de Lille France
Lille, France
Recruiting - Local Institution - 09601
Lyon, France
Withdrawn - Local Institution - 09400
Marseille, France
Completed - Local Institution - 09602
Marseille, France
Withdrawn - Chu Montpellier - Hôpital Saint Eloi
Montpellier, France
Recruiting - Chu Hotel Dieu
Nantes, France
Recruiting - Hopital Saint Louis
Paris, France
Recruiting - Hospital Saint Louis
Paris, France
Recruiting - Hôpitaux Universitaires Pitie Salpêtrière Charles Foix
Paris, France
Recruiting - Local Institution - 09600
Paris, France
Withdrawn - Centre Hospitalier Universitaire (chu) de Bordeaux - Hopital Haut-Leveque
Pessac, France
Recruiting - Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
Recruiting - Chu la Miletrie
Poitiers, France
Recruiting - Hopital Sud
Rennes, France
Recruiting - Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, France
Recruiting - Gustave Roussy
Villejuif, France
Recruiting
- Local Institution - 03155
Berlin, Germany
Not, yet, recruiting - Robert-Rossle-Klinik Im Helios Klinikum Berlin-Buch Klinik Fur Hamatologie, Onkologie U. Tumorimmuno
Berlin, Germany
Recruiting - Kinikum Der Universitaeat Zu Koeln
Cologne, Germany
Recruiting - Universitatsklinikum Carl Gustav Carus An Der Tu Dresden
Dresden, Germany
Recruiting - Local Institution - 03513
Düsseldorf, Germany
Withdrawn - Local Institution - 03500
Frankfurt, Germany
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jul 2018
- Primary completion
- 30 Nov 2036
- Completion
- 30 Nov 2036
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 1,541
- Registry id
- NCT03435796
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.